<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00594269</url>
  </required_header>
  <id_info>
    <org_study_id>F06001</org_study_id>
    <nct_id>NCT00594269</nct_id>
  </id_info>
  <brief_title>Dementia Antipsychotics And Antidepressants Discontinuation Study</brief_title>
  <acronym>DESEP</acronym>
  <official_title>Discontinuation of Antipsychotics and Antidepressants Among Patients With Dementia and BPSD Living in Nursing Homes - a 24 Weeks Double Blind RCT.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sykehuset Innlandet HF</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ullevaal University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eikertun Nursing Home</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Bergen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Innlandet Hospital Trust, Sanderud</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Innlandet Hospital Trust, Reinsvoll</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Diakonhjemmet Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sykehuset Telemark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Nordmøre and Romsdal Hospital Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Songdalstunet Nursing Home</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sykehuset Buskerud HF</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kroken Nursing Home, Tromsø</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kløveråsen, Bodø</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bjørgene Omsorgssenter, Haugesund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Alesund Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sykehuset Innlandet HF</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to discontinue antipsychotics and antidepressants, and to study its
      effect on Behavioural- and Psychological Symptoms in Dementia (BPSD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with dementia have cognitive deficits, but also hallucinations, delusions,
      agitation, aggression and apathy. These symptoms are called Behavioural- and Psychological
      Symptoms in Dementia (BPSD), and are difficult to treat. Antipsychotic and antidepressant
      medication is used as treatment, despite its lack of clinical evidence.

      We will discontinue risperidone in one group of 30 patients and compere them to 30 controls
      and we will discontinue antidepressants in a group of 76 patients and compere them to 76
      controls. Patients should have dementia of Alzheimer- or vascular origin. They should live in
      Nursing Homes and have no other psychiatric disease for which they receive psychotropic drug.
      They will be registered with 7 different questionnaires at baseline and after 3, 6, 12 and 24
      weeks. The study period is 24 weeks. The questionnaires are filled in by the patients and the
      nurses at the nursing homes.

      This is a double blind RCT study with placebo-controlled group.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in Neuropsychiatric Inventory</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in Cornell's Depression Scale</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in UPDRS subscale</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in Severe Impairment Battery</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Lawton's PADL</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxazepam given p.n.</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of falls</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Body Weight</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life - Alzheimer disease</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Dementia Rating</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">149</enrollment>
  <condition>Dementia</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Discontinuation of antipsychotic or antidepressants</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Risperidone</intervention_name>
    <description>Discontinuation</description>
    <arm_group_label>A</arm_group_label>
    <other_name>ATC code N05AX 08</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Escitalopram</intervention_name>
    <description>Discontinuation</description>
    <arm_group_label>A</arm_group_label>
    <other_name>ATC code N06AB 10</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Citalopram</intervention_name>
    <description>Discontinuation</description>
    <arm_group_label>A</arm_group_label>
    <other_name>ATC code N06AB 04</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sertraline</intervention_name>
    <description>Discontinuation</description>
    <arm_group_label>A</arm_group_label>
    <other_name>ATC code N06AB 06</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paroxetine</intervention_name>
    <description>Discontinuation</description>
    <arm_group_label>A</arm_group_label>
    <other_name>ATC code N06AB 05</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Vascular- or Alzheimer Dementia

          -  Nursing Homes resident for 3 months or more

          -  Given antipsychotics or antidepressants for 3 months or more

          -  Clinical Dementia rating 1, 2 or 3

        Exclusion Criteria:

          -  Dementia of other origin

          -  Psychiatric disease

          -  Life expectancy less than 3 months

          -  Acute infection last 10 days

          -  Unstable Diabetes Mellitus

          -  Terminal disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Knut Engedal, Ph D</last_name>
    <role>Study Chair</role>
    <affiliation>The Norwegian Centre for Dementia Research (NCDR), Norway</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sverre Bergh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Innlandet Hospital Trust, Sanderud</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sykehuset Innlandet HF - Sanderud</name>
      <address>
        <city>Ottestad</city>
        <state>Oppland</state>
        <zip>2312</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sykehuset Innlandet HF</name>
      <address>
        <city>Reinsvoll</city>
        <state>Oppland</state>
        <zip>2840</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Bergen, Løvaasen Nursing Home</name>
      <address>
        <city>Bergen</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eikertun Nursing Home</name>
      <address>
        <city>Hokksund</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Nordmøre and Romsdal Hospital Trust</name>
      <address>
        <city>Molde</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diakonihjemmets Hospital</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ullevaal University Hospital</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Telemark Hospital</name>
      <address>
        <city>Skien</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 3, 2008</study_first_submitted>
  <study_first_submitted_qc>January 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2008</study_first_posted>
  <last_update_submitted>February 22, 2011</last_update_submitted>
  <last_update_submitted_qc>February 22, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 23, 2011</last_update_posted>
  <responsible_party>
    <name_title>Sverre Bergh, Cand Med, Researcher.</name_title>
    <organization>Innlandet Hospital Trust</organization>
  </responsible_party>
  <keyword>Antidepressants</keyword>
  <keyword>Antipsychotics</keyword>
  <keyword>Dementia</keyword>
  <keyword>Discontinuation study</keyword>
  <keyword>Behavioural- and Psychological Symptoms in Dementia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antidepressive Agents</mesh_term>
    <mesh_term>Citalopram</mesh_term>
    <mesh_term>Sertraline</mesh_term>
    <mesh_term>Paroxetine</mesh_term>
    <mesh_term>Risperidone</mesh_term>
    <mesh_term>Antipsychotic Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

